{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:27:16Z","timestamp":1708043236813},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,15]]},"DOI":"10.7759\/cureus.54225","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T09:55:31Z","timestamp":1707990931000},"source":"Crossref","is-referenced-by-count":0,"title":["Granulomas Galore: Concomitant Granulomatous Infections in a Patient With Crohn's Disease"],"prefix":"10.7759","author":[{"given":"Michael","family":"Gianarakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Gianarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Pueringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ushan","family":"Ranasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969110-00002","article-title":"Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy","volume":"69","author":"Smith JA","year":"2009","unstructured":"Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy. Drugs. 2009, 69:1403-15. 10.2165\/00003495-200969110-00002","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.12-0292","article-title":"Tuberculosis and histoplasmosis co-infection in AIDS patients","volume":"87","author":"Agudelo CA","year":"2012","unstructured":"Agudelo CA, Restrepo CA, Molina DA, Tob\u00f3n AM, Kauffman CA, Murillo C, Restrepo A. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012, 87:1094-8. 10.4269\/ajtmh.2012.12-0292","journal-title":"Am J Trop Med Hyg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-2097-7","article-title":"Concomitant disseminated histoplasmosis and disseminated tuberculosis after tumor necrosis factor inhibitor treatment: a case report","volume":"17","author":"Mu\u00f1oz-Oca JE","year":"2017","unstructured":"Mu\u00f1oz-Oca JE, Villarreal Morales ML, Nieves-Rodriguez A, Mart\u00ednez-Bonilla L. Concomitant disseminated histoplasmosis and disseminated tuberculosis after tumor necrosis factor inhibitor treatment: a case report. BMC Infect Dis. 2017, 17:70. 10.1186\/s12879-016-2097-7","journal-title":"BMC Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.07.011","article-title":"Screening for tuberculosis infection prior to initiation of anti-TNF therapy","volume":"8","author":"Lalvani A","year":"2008","unstructured":"Lalvani A, Millington KA. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev. 2008, 8:147-52. 10.1016\/j.autrev.2008.07.011","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2007.48.3.531","article-title":"Disseminated histoplasmosis and tuberculosis in a patient with HIV infection","volume":"48","author":"Jeong HW","year":"2007","unstructured":"Jeong HW, Sohn JW, Kim MJ, et al.. Disseminated histoplasmosis and tuberculosis in a patient with HIV infection. Yonsei Med J. 2007, 48:531-4. 10.3349\/ymj.2007.48.3.531","journal-title":"Yonsei Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa119","article-title":"Chronic pulmonary histoplasmosis\u2014a scoping literature review","volume":"7","author":"Baker J","year":"2020","unstructured":"Baker J, Kosmidis C, Rozaliyani A, Wahyuningsih R, Denning DW. Chronic pulmonary histoplasmosis\u2014a scoping literature review. Open Forum Infect Dis. 2020, 7:ofaa119. 10.1093\/ofid\/ofaa119","journal-title":"Open Forum Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir435","article-title":"A multicenter evaluation of tests for diagnosis of histoplasmosis","volume":"53","author":"Hage CA","year":"2011","unstructured":"Hage CA, Ribes JA, Wengenack NL, et al.. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011, 53:448-54. 10.1093\/cid\/cir435","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050437","article-title":"Effect of rifampicin on the pharmacokinetics of itraconazole in normal volunteers and AIDS patients","volume":"54","author":"Jaruratanasirikul S","year":"1998","unstructured":"Jaruratanasirikul S, Sriwiriyajan S. Effect of rifampicin on the pharmacokinetics of itraconazole in normal volunteers and AIDS patients. Eur J Clin Pharmacol. 1998, 54:155-8. 10.1007\/s002280050437","journal-title":"Eur J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60333-0","article-title":"Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial","volume":"373","author":"Conde MB","year":"2009","unstructured":"Conde MB, Efron A, Loredo C, et al.. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet. 2009, 373:1183-9. 10.1016\/S0140-6736(09)60333-0","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy","volume":"81","author":"Shelburne SA 3rd","year":"2002","unstructured":"Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, et al.. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore). 2002, 81:213-27. 10.1097\/00005792-200205000-00005","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ299","article-title":"Histoplasmosis complicating tumor necrosis factor-\u03b1 blocker therapy: a retrospective analysis of 98 cases","volume":"61","author":"Vergidis P","year":"2015","unstructured":"Vergidis P, Avery RK, Wheat LJ, et al.. Histoplasmosis complicating tumor necrosis factor-\u03b1 blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015, 61:409-17. 10.1093\/cid\/civ299","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy131","article-title":"An interferon gamma release assay specific for Histoplasma capsulatum to detect asymptomatic infected individuals: a proof of concept study","volume":"57","author":"Rubio-Carrasquilla M","year":"2019","unstructured":"Rubio-Carrasquilla M, Santa CD, Rend\u00f3n JP, Botero-Garc\u00e9s J, Guimar\u00e3es AJ, Moreno E, Cano LE. An interferon gamma release assay specific for Histoplasma capsulatum to detect asymptomatic infected individuals: a proof of concept study. Med Mycol. 2019, 57:724-32. 10.1093\/mmy\/myy131","journal-title":"Med Mycol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2021.AB008","article-title":"AB008. Utility of repeat latent tuberculosis testing in patients with immune-mediated diseases taking biologics","volume":"9","author":"Khanna U","year":"2021","unstructured":"Khanna U, Ellis A, Gallop J, Galadari A, Hu J, Fernandez AP. AB008. Utility of repeat latent tuberculosis testing in patients with immune-mediated diseases taking biologics. Ann Transl Med. 2021, 9:AB008. 10.21037\/atm.2021.AB008","journal-title":"Ann Transl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh JA","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, et al.. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012, 64:625-39. 10.1002\/acr.21641","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-10-200711200-00006","article-title":"Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab","volume":"147","author":"Raval A","year":"2007","unstructured":"Raval A, Akhavan-Toyserkani G, Brinker A, Avigan M. Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab. Ann Intern Med. 2007, 147:699-702. 10.7326\/0003-4819-147-10-200711200-00006","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/221232-granulomas-galore-concomitant-granulomatous-infections-in-a-patient-with-crohns-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T09:55:48Z","timestamp":1707990948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/221232-granulomas-galore-concomitant-granulomatous-infections-in-a-patient-with-crohns-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.54225","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}